32 research outputs found
Substitution and pooling in crowding
Unless we fixate directly on it, it is hard to see an object among other objects. This breakdown in object recognition, called crowding, severely limits peripheral vision. The effect is more severe when objects are more similar. When observers mistake the identity of a target among flanker objects, they often report a flanker. Many have taken these flanker reports as evidence of internal substitution of the target by a flanker. Here, we ask observers to identify a target letter presented in between one similar and one dissimilar flanker letter. Simple substitution takes in only one letter, which is often the target but, by unwitting mistake, is sometimes a flanker. The opposite of substitution is pooling, which takes in more than one letter. Having taken only one letter, the substitution process knows only its identity, not its similarity to the target. Thus, it must report similar and dissimilar flankers equally often. Contrary to this prediction, the similar flanker is reported much more often than the dissimilar flanker, showing that rampant flanker substitution cannot account for most flanker reports. Mixture modeling shows that simple substitution can account for, at most, about half the trials. Pooling and nonpooling (simple substitution) together include all possible models of crowding. When observers are asked to identify a crowded object, at least half of their reports are pooled, based on a combination of information from target and flankers, rather than being based on a single letter
Prevalence of long face pattern in Brazilian individuals of different ethnic backgrounds
Recommended from our members
A second update on mapping the human genetic architecture of COVID-19
Matters Arising From: COVID-19 Host Genetics Initiative. Nature https://doi.org/10.1038/s41586-021-03767-x (2021)Data availability:
Summary statistics generated by the COVID-19 HGI are available online, including per-ancestry summary statistics for African, admixed American, East Asian, European and South Asian ancestries (https://www.covid19hg.org/results/r7/). The analyses described here used the data release 7. If available, individual-level data can be requested directly from contributing studies, listed in Supplementary Table 1. We used publicly available data from GTEx (https://gtexportal.org/home/), the Neale laboratory (http://www.nealelab.is/uk-biobank/), the Finucane laboratory (https://www.finucanelab.org), the FinnGen Freeze 4 cohort (https://www.finngen.fi/en/access_results) and the eQTL catalogue release 3 (http://www.ebi.ac.uk/eqtl/).Code availability:
The code for summary statistics lift-over, the projection PCA pipeline including precomputed loadings and meta-analyses (https://github.com/covid19-hg/); for heritability estimation (https://github.com/AndrewsLabUCSF/COVID19_heritability); for Mendelian randomization and genetic correlation (https://github.com/marcoralab/MRcovid); and subtype analyses (https://github.com/mjpirinen/covid19-hgi_subtypes) are available at GitHub.Reporting summary:
Further information on research design is available in the Nature Portfolio Reporting Summary linked to this article online at: https://www.nature.com/articles/s41586-023-06355-3#MOESM2 .Supplementary information is available online at: https://www.nature.com/articles/s41586-023-06355-3#Sec4 .Copyright © The Author(s) 2023. Investigating the role of host genetic factors in COVID-19 severity and susceptibility can inform our understanding of the underlying biological mechanisms that influence adverse outcomes and drug development1,2. Here we present a second updated genome-wide association study (GWAS) on COVID-19 severity and infection susceptibility to SARS-CoV-2 from the COVID-19 Host Genetic Initiative (data release 7). We performed a meta-analysis of up to 219,692 cases and over 3 million controls, identifying 51 distinct genome-wide significant loci—adding 28 loci from the previous data release2. The increased number of candidate genes at the identified loci helped to map three major biological pathways that are involved in susceptibility and severity: viral entry, airway defence in mucus and type I interferon